Skip to main content
OpenTrials
Completed

NCT Number: NCT04082819

MediBeat - HeartBeat Observation Trial

The goal of the study was to compare the current gold standard blood pressure instrument (a mercury-filled sphygmomanometer with cuff and stethoscope) with the new experimental algorithm developed by HeartBeat Technologies Ltd. To that end, participants were recruited from Markham, Ontario and participated in a series of alternating blood pressure measurements over a period of 45 minutes. Comparisons were made between manual measurements and device measurements to determine the quality of the device readings. Measurements were taken by trained nurses and staff were consistent across the study duration.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Low Blood Pressure Blood Pressure Cardiovascular Diseases High Blood Pressure Hypertension Hypotension Vascular Diseases

Age range

25 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

SE Health

Markham, Ontario, L3R 6H3, Canada

About this study

The gold standard instrument for blood pressure measurement is a mercury-filled sphygmomanometer with cuff and stethoscope (Canadian Agency for Drugs and Technologies in Health; Canadian Electronic Library, 2012). However, such a device is not the most convenient for client self-monitoring or virtual (remote) care. Thus, there is a desire for an accurate, reliable alternative for the traditional mercury-containing sphygmomanometer.

HeartBeat Technologies Ltd. ("Heartbeat") has developed a novel approach to measuring blood pressure after an initial blood pressure reading using the conventional measurement method, supplemented by specific characteristics of a person (age, gender, height, weight, and heart rate), has established a "baseline measurement" for the person. The "novel approach" uses a finger pulse oximeter, the Contec CMS50EW device (Figure 1) (manufactured by Contec Medical Systems Co., Ltd., Shanghai, People's Republic of China). The finger pulse oximeter detects the changes in blood volume directly below the person's skin and indirectly measures oxygen saturation in the blood. The measurement is in the form of a photoplethysmogram (PPG) which is captured by the Contec oximeter and then, by Bluetooth technology, transmitted to a smartphone or tablet. A HeartBeat application, called MediBeat, on the smartphone or tablet then transmits the PPG to a server where a proprietary algorithm analyzes the baseline measurement for the person and the PPG to calculate the person's current blood pressure.

Heartbeat's intent is that the current blood pressure reading would then be made available to both the client and the health provider through separate web-based interfaces. Providers would be able to log onto the HeartBeat web-based application from anywhere to review and monitor the blood pressure of multiple clients, while clients can log onto the application to track their own measurements.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • adult over 25 years of age

Exclusion criteria

  • those who have heart arrhythmias,
  • atrial fibrillations or atrial flutters,
  • an inaudible Korotkoff sound,
  • wounds of the upper arms/wrists, missing fingers, and/or
  • an arm circumference of more than 55 cm will be excluded

Treatment and study plan

Contec CMS50EW

Device

Participants' blood pressure will be measured 3 times with the wearable finger pulse oximeter at their study visit.

sphygmomanometer

Device

Participants' blood pressure will be measured 4 times manually with a blood pressure cuff at their study visit.

Primary outcomes

  1. Difference Between Systolic Manual Sphygmomanometer and Finger Pulse Oximeter Readings

    Time frame: 45 - 60 minutes

    Each device reading was compared to the manual blood pressure reading taken before (R1) and after it (R2). The degree of alignment for systolic blood pressure was calculated by taking the difference between the two scores (manual and device). The reading with the best alignment was used.

  2. Difference Between Diastolic Manual and Device Blood Pressure Readings

    Time frame: 45-60 minutes

    Each device reading was compared to the manual reading before (R1) and after (R2) it, to calculate the degree of alignment. The difference of the device and R1, and the device and R2 were taken. The smaller number was used for results reporting.

Sponsors and collaborators

Lead sponsor

SE Health

Other

Collaborators

  • Centre for Aging and Brain Health Innovation

Registry information

Official study title

Determining the Accuracy of the HeartBeat Algorithm for Calculating Blood Pressure

Important dates

Study start
2019
Primary completion
2019
Study completion
2019
First posted
Sep 9, 2019
Registry last updated
Apr 1, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.